GT Biopharma Inc. (GTBP) PT Lowered to $18 at B.Riley
Tweet
Share
E-mailGet Alerts GTBP Hot Sheet
Price: $0.30 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
B.Riley analyst Chad Mabry lowered the price target on GT Biopharma Inc. (NASDAQ: GTBP) to $18.00 (from $26.00) while maintaining a Buy rating.
You May Also Be Interested In
- GT Biopharma Reports Second Quarter 2026 Financial Results
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
